Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00009779
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this study is to evaluate the efficacy and safety of upadacitinib compared
to placebo as induction therapy in adults with moderately and severely active Crohn's disease
(CD).
创建时间：
2026-01-28
